These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 5010725)
1. Successful medical management of osteitis fibrosa due to "tertiary" hyperparathyroidism. Vosik WM; Anderson CF; Steffee WP; Johnson WJ; Arnaud CD; Goldsmith RS Mayo Clin Proc; 1972 Feb; 47(2):110-3. PubMed ID: 5010725 [No Abstract] [Full Text] [Related]
2. Hypo-hyperparathyroidism due to renal resistance to parathyroid hormones. Ebrahimi MA; Nik-Akhtar B Br J Clin Pract; 1979 Jul; 33(7):209-14. PubMed ID: 526426 [No Abstract] [Full Text] [Related]
3. [Outcome of osseous lesions of hyperparathyroidism in a patient with chronic renal failure treated with high doses of vitamin D]. Verberckmoes R; Tanghe W; Michielsen P; Vandenbroucke J J Urol Nephrol (Paris); 1970 Sep; 76(9):790-7. PubMed ID: 5482082 [No Abstract] [Full Text] [Related]
4. [A case from practice (46). Patient: E. M., born 1926 (chronic kidney failure, hyperparathyroidism, osteomalacia)]. Bally K Schweiz Rundsch Med Prax; 1986 Jan; 75(3):48-9. PubMed ID: 3952404 [No Abstract] [Full Text] [Related]
5. Uremic osteodystrophy. The therapeutic consequences of effective control of serum phosphorus. Pinggera WF; Popovtzer MM JAMA; 1972 Dec; 222(13):1640-2. PubMed ID: 4678366 [No Abstract] [Full Text] [Related]
6. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis. Genuth SM; Sherwood LM; Vertes V; Leonards JR J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532 [No Abstract] [Full Text] [Related]
7. [Dialysis bone disease associated with secondary hyperparathyroidism]. Nakazawa R Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767 [No Abstract] [Full Text] [Related]